Mark D Titus

Title: Innovator Mark D. Titus: Pioneering Veterinary Vaccines

Introduction: Mark D. Titus, an accomplished inventor based in Jackson, Minnesota, has made significant contributions to the field of veterinary medicine. With a focus on developing effective vaccines for livestock, Titus has secured a patent that reflects his innovative approach to animal health.

Latest Patents: Mark D. Titus holds one patent for a groundbreaking invention: a culture of cells exhibiting attenuated pathogenicity, capable of triggering a protective immune response when administered to pigs as a live vaccine. This invention also encompasses a method of preparing the cell culture, a method of preparing a vaccine from the cell culture, and the live vaccine itself. This innovative approach was achieved through MNNG mutagenesis on a pathogenic parent strain, with careful selection based on complete dependence on streptomycin for growth.

Career Highlights: Titus has built a successful career at Newport Laboratories, a company dedicated to advancing animal health solutions. His expertise in vaccine development positions him as a key player within the organization, making strides in the fight against livestock diseases.

Collaborations: Throughout his career, Mark D. Titus has collaborated with esteemed coworkers such as Simone Oliveira and Randy R. Simonson. Their combined efforts and shared knowledge contribute to the advancement of veterinary medicine, particularly in the development of effective vaccines.

Conclusion: Mark D. Titus’s innovative spirit and dedication to improving animal health through his patented inventions underscore the importance of research and collaboration in the field. His work not only benefits the livestock industry but also paves the way for future advancements in veterinary vaccines.